Pacific Urology Designated as a Center of Excellence for Rezūm Water Vapor Therapy, a Treatment for Benign Prostatic Hyperplasia (BPH), or Enlarged Prostate

Center of Excellence recognizes high degree of experience with new technology

Rezūm Center of Excellence Certificate | Pacific Urology | San Ramon, CASan Ramon, CA – February 26, 2020Pacific Urology and Parminder Sethi, M.D., announced today that they have been designated a Center of Excellence and Center of Excellence provider for Rezūm Water Vapor Therapy treatment, a minimally invasive, in-office procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms.

Rezūm therapy uses natural water vapor to reduce the size of the prostate and provide lasting symptom relief from BPH without invasive surgery or some of the potential side effects of prescription drugs.1 The Center of Excellence designation recognizes Dr. Parminder Sethi’s high degree of experience with Rezūm Water Vapor Therapy and commitment to delivering significant, lasting symptom relief to men suffering from benign prostatic hyperplasia (BPH).1

BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2

“Being designated as a Rezūm Center of Excellence is a meaningful recognition for us, as we strive to provide the best possible treatment of urological conditions for patients in the San Francisco East Bay area,” said Dr. Sethi. “For years, the primary options for treating BPH were through behavior modifications, medications or invasive surgery. However, medications may not work for everyone and may have undesirable side effects such as dizziness, sexual dysfunction and lower sex drive.3 With Rezūm therapy, we’re able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery and implants.”

During Rezūm therapy, which takes place during one short office visit, natural water vapor is released throughout the targeted prostate tissue. When the steam contacts the tissue and turns back to water, it releases energy, killing the excess prostate cells that squeeze the urethra. Over time, the body’s natural healing response removes the dead cells and shrinks the prostate. With the extra tissue removed, the urethra opens, relieving BPH symptoms while preserving erectile and urinary function.1 The procedure does not require general anesthesia and is performed under oral sedation or local anesthesia.1

Rezūm therapy is currently being used in many leading urology practices throughout the United States. To date, more than 55,000 patients around the world have been successfully treated with Rezūm therapy. 5

About Pacific Urology

With clinics in Concord, Walnut Creek, Brentwood and San Ramon, Pacific Urology is one of the San Francisco Bay Area’s largest urology practices. Pacific Urology restores urologic health for men, women and children, and treats numerous health issues including overactive bladder, prostate cancer, kidney stones, bladder and kidney cancer, erectile dysfunction, incontinence, infertility and more, while also performing vasectomy and vasectomy reversal. www.PacificUrology.com.

  1. McVary KT, Rogers T, Roehrborn CG. Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019 Apr;126:171-9.
  2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic- hyperplasia-(bph). Accessed August 5, 2019.
  3. Roger K and Gilling P. Fast Facts: Benign Prostatic Hyperplasia, 7th edition. Health Press. 2011.
  4. McVary KT, Gange SN, Gittleman MC et al. Minimally invasive prostate convective water vapor energy (WAVE) ablation: A multicenter, randomized, controlled study for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016 May;195(5):1529-38.
  5. Date on file with Boston Scientific.